Categorized | Latest Business News

J&J accepts $2.1 billion bid for its LifeScan diabetes business – CNBC

Posted on 12 June 2018 by admin


CNBC

J&J accepts $2.1 billion bid for its LifeScan diabetes business
CNBC
Johnson & Johnson has accepted an offer of about $2.1 billion for its LifeScan business from private equity firm Platinum Equity. J&J announced in March it received the firm's offer for the blood glucose monitor business, which generated net revenue of ...

and more »

Comments are closed.